301 related articles for article (PubMed ID: 20730698)
1. Chronic kidney disease-associated anemia: new remedies.
Del Vecchio L; Cavalli A; Tucci B; Locatelli F
Curr Opin Investig Drugs; 2010 Sep; 11(9):1030-8. PubMed ID: 20730698
[TBL] [Abstract][Full Text] [Related]
2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
3. Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications.
Macdougall IC; Ashenden M
Adv Chronic Kidney Dis; 2009 Mar; 16(2):117-30. PubMed ID: 19233071
[TBL] [Abstract][Full Text] [Related]
4. Peginesatide: a potential erythropoiesis stimulating agent for the treatment of anemia of chronic renal failure.
Doss S; Schiller B
Nephrol Nurs J; 2010; 37(6):617-26. PubMed ID: 21290916
[TBL] [Abstract][Full Text] [Related]
5. [Treatment anaemia of chronic kidney disease in predialysis patients (stage 1-4)].
Lovcić V; Vujić J; Ivanac Janković R; Basić-Jukić N; Barisić I; Lovcić P; Dzapo M
Acta Med Croatica; 2009 Sep; 63 Suppl 1():11-6. PubMed ID: 20232547
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in erythropoietic agents in renal anemia.
Macdougall IC
Semin Nephrol; 2006 Jul; 26(4):313-8. PubMed ID: 16949470
[TBL] [Abstract][Full Text] [Related]
7. New anemia therapies: translating novel strategies from bench to bedside.
Macdougall IC
Am J Kidney Dis; 2012 Mar; 59(3):444-51. PubMed ID: 22192713
[TBL] [Abstract][Full Text] [Related]
8. Triumph and tragedy: anemia management in chronic kidney disease.
Novak JE; Szczech LA
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
[TBL] [Abstract][Full Text] [Related]
9. New Treatment Approaches for the Anemia of CKD.
Bonomini M; Del Vecchio L; Sirolli V; Locatelli F
Am J Kidney Dis; 2016 Jan; 67(1):133-42. PubMed ID: 26372086
[TBL] [Abstract][Full Text] [Related]
10. [Erythropoesis-stimulating agents: past, present and future].
Kes P; Basić-Jukić N
Acta Med Croatica; 2009 Sep; 63 Suppl 1():3-6. PubMed ID: 20235351
[TBL] [Abstract][Full Text] [Related]
11. Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management.
Kanbay M; Perazella MA; Kasapoglu B; Koroglu M; Covic A
Blood Purif; 2010; 29(1):1-12. PubMed ID: 19816014
[TBL] [Abstract][Full Text] [Related]
12. Novel erythropoiesis-stimulating agents: a new era in anemia management.
Macdougall IC
Clin J Am Soc Nephrol; 2008 Jan; 3(1):200-7. PubMed ID: 18077782
[TBL] [Abstract][Full Text] [Related]
13. Hematide™ for the treatment of chronic kidney disease-related anemia.
Locatelli F; Del Vecchio L
Expert Rev Hematol; 2009 Aug; 2(4):377-83. PubMed ID: 21082943
[TBL] [Abstract][Full Text] [Related]
14. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
15. Peginesatide for the treatment of renal disease-induced anemia.
Schmid H
Expert Opin Pharmacother; 2013 May; 14(7):937-48. PubMed ID: 23506424
[TBL] [Abstract][Full Text] [Related]
16. Anemia in renal disease: diagnosis and management.
Lankhorst CE; Wish JB
Blood Rev; 2010 Jan; 24(1):39-47. PubMed ID: 19833421
[TBL] [Abstract][Full Text] [Related]
17. Iron therapy in chronic kidney disease: current controversies.
Kovesdy CP; Kalantar-Zadeh K
J Ren Care; 2009 Dec; 35 Suppl 2():14-24. PubMed ID: 19891681
[TBL] [Abstract][Full Text] [Related]
18. Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation.
Adamson JW
Adv Chronic Kidney Dis; 2009 Mar; 16(2):76-82. PubMed ID: 19233066
[TBL] [Abstract][Full Text] [Related]
19. Optimizing anemia management in hospitalized patients with end-stage renal disease.
Heung M; Mueller BA; Segal JH
Ann Pharmacother; 2009 Feb; 43(2):276-82. PubMed ID: 19141655
[TBL] [Abstract][Full Text] [Related]
20. Renal anaemia: recent developments, innovative approaches and future directions for improved management.
Kerr PG
Nephrology (Carlton); 2006 Dec; 11(6):542-8. PubMed ID: 17199795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
